Binjiang Pharma, Inc. is a biopharmaceutical company focused on the drug dicovery, process development and customer service. The company consists of high Ph.D. ratios and operates facilities in Tianjin International Joint Academy of Biotechnology & Medicine (TJAB) recogenized as a key bio-tech company by Tianjin City. The company strategy is to invent targeted small molecule drugs with a competitive advantage over existing therapies and co-develop the drugs with partners. In the meantime, the company provides high quality R&D services for pharmaceutical companies, such as customer synthesis, FTE contract research and process development with timeline control and competitive prices. Binjiang Pharma strictly executes the regulation of IP protection for our customers, which in turn has rewarded Binjiang Pharma with satisfied and long term customer contracts from USA, Europe and Japan. Binjiang Pharma’s research and production unit are facilitated with state-of-the-art QA/QC including 400 MHz NMR, 600 MHz NMR, LC-MS, HPLC, and GC etc.